BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oxford Society of Ageing and Longevity - ECPv6.13.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.ageingandlongevity.org
X-WR-CALDESC:Events for Oxford Society of Ageing and Longevity
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260216T180000
DTEND;TZID=UTC:20260216T180000
DTSTAMP:20260423T205000
CREATED:20260210T150858Z
LAST-MODIFIED:20260210T150920Z
UID:1206-1771264800-1771264800@www.ageingandlongevity.org
SUMMARY:Genflow Biosciences: Translating longevity research to the bedside
DESCRIPTION:Dr. Eric Leire is the Founder and CEO of Genflow Biosciences\, a longevity gene therapy company listed on the London Stock Exchange. An MD and MBA (HEC/Kellogg)\, he combines research experience from the Harvard AIDS Institute with executive leadership at Pfizer and Biofund Venture Capital. Dr. Leire has guided multiple biotech companies to public listings (Nasdaq) and holds several pharmaceutical patents.
URL:https://www.ageingandlongevity.org/event/genflow-biosciences-translating-longevity-research-to-the-bedside/
LOCATION:David Smith Lecture Theatre Department of Pharmacology Mansfield Road Oxford OX1 3QT United Kingdom\, David Smith Lecture Theatre Department of Pharmacology Mansfield Road\, Oxford United Kingdom\, OX1 3QT\, United Kingdom
ATTACH;FMTTYPE=image/png:https://www.ageingandlongevity.org/wp-content/uploads/2026/02/GenflowBiosciences.png
END:VEVENT
END:VCALENDAR